International nonproprietary names for biological and biotechnological drugs
The article presents generalized information about the program of the World Health Organization (WHO) related to International Nonproprietary Names (INN) of biological and biotechnological drugs. It reflects general principles for selecting INN for biological and biotechnological preparations, immun...
Saved in:
Main Authors: | V. V. Dudchenko, P. I. Popov, N. D. Bunyatyan, A. N. Yavorsky, V. A. Merkulov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
2018-02-01
|
Series: | Регуляторные исследования и экспертиза лекарственных средств |
Subjects: | |
Online Access: | https://www.vedomostincesmp.ru/jour/article/view/62 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
International nonproprietary names of drugs: requirements for an application and order of examination and registration of the world health organization
by: V. V. Dudchenko, et al.
Published: (2018-02-01) -
Group names for herbal medicines: the need for introduction and rationale for establishing
by: M. N. Lyakina, et al.
Published: (2018-02-01) -
Modern biological/biotechnological medicinal products. Topical issues and prospects for development
by: Yu. V. Olefir, et al.
Published: (2018-02-01) -
Safety of biological preparations. Report 1. Terminology and classification issues
by: A. A. Soldatov, et al.
Published: (2018-02-01) -
The history of development of Pharmacopoeia standards quality biological drugs and methods of tests in Russia
by: T. M. Kargina, et al.
Published: (2018-02-01)